Searched for
BIOTECH EXPORT RESTRICTIONS
China eyes curbs on AI, biotech, solar exportsChina has unveiled a draft for export controls targeting artificial intelligence and biotechnology technologies, aiming to impose a total b...- Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...
- Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
- As private wallets begin to open, India's big future bet takes offIndia’s Rs 1 lakh crore RDI programme is beginning to unlock venture capital flows into deeptech, marking a shift in the country’s attempt ...
- Pharma sector must attract more investment in clinical trials, R&D: Piyush GoyalPiyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...
- When frontier AI can be switched off: India's sovereignty challengeIndia must not depend on foreign AI models, as US export controls demonstrate potential access denial. Past reliance on external tech, like...
- Budget 2026: Customs duty waiver likely for SEZ-made drugs sold locallyIndia may soon waive customs duty on medicines produced in special economic zones for local sale. This move aims to reduce costs and increa...
- From tungsten to cars: China imposes new taxes on US goodsThe tariffs set by China will take effect on February 10. China’s Ministry of Commerce and Customs Administration also imposed immediate ex...
- Covaxin gets WHO approval for emergency use listingWHO's TAG is an independent advisory group that provides recommendations to the WHO on whether a Covid 19 vaccine can be listed for emergen...
- Technical Advisory Group seeks additional clarification on Covaxin for Emergency Use ListingWhile the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Jans...
- WHO's advisory group set to meet on October 26 to decide on Covaxin EUL approvalWhile the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Jans...
- WHO advisory group to meet on Oct 26 to decide on Bharat Biotech’s CovaxinWHO had earlier said that Bharat Biotech has been submitting data to it on a rolling basis and had submitted additional information on 27 S...
- WHO may take a call on Covaxin todayThe company said last week that it was diligently working with the WHO to obtain Emergency Use Listing (EUL) at the earliest adding it is n...
- WHO to decide on Bharat Biotech's Covaxin clearance in OctoberSoumya Swaminathan, WHO's chief scientist, told ET that the "process is ongoing".
- WHO to review Covaxin; emergency use approval may come by mid-SeptemberThe WHO global advisory committee on vaccine safety will assess immunogenicity, vaccine safety and vaccine effectiveness of Covaxin, a cruc...
- Bharat Biotech officials to meet WHO assessors next weekA pre-submission meeting provides an opportunity to the company for advice and guidance before submission of the final dossier, as well as ...
- Mobilising nation against CovidThe government must also work out models and modules for improvised hospitals for Covid care, including oxygen delivery systems simpler tha...
- Max the Vax: India has a unique opportunity to be the world's saviourIncreasing global vaccine supplies calls for global coordination. Vaccine know-how must be made available without any intellectual property...
- Bharat Biotech's subsidiary Chiron Behring launches anti-rabies vaccine“In our ongoing commitment to address the supply shortages of rabies vaccine, we are making additional investments to increase production c...
- India's biotech sector to grow 20% in foreseeable futureMazumdar-Shaw said the size of the country's biotech sector had reached USD 3.5 billion in 2010 and is poised for robust growth in all segm...
Load More
